Fintech PR
CGTN：How China, S Africa usher in ‘golden era’ for bilateral ties
BEIJING, Aug. 23, 2023 /PRNewswire/ — With a brotherly and comradely friendship, China and South Africa – the world’s two major developing countries – are set to see their bilateral relations taking a step further with more fruitful cooperation in a “golden era” as the leaders of both countries met in Pretoria on Tuesday.
During his meeting with South African President Cyril Ramaphosa, Xi recalled the fruits of bilateral cooperation in the past decade, including the building of Chinese carmaker BAIC Group’s South Africa plant and the establishment of the Confucius Institute at Durban University of Technology in 2013, saying that he is pleased to see the progress South Africa has achieved in national development.
In 2018, Xi and Ramaphosa unveiled the first-ever BAIC vehicle assembled on African soil via video link. In celebration of South Africa hosting the 15th BRICS Summit, the BAIC Group South Africa plant is set to realize the localized production of BAIC’s own brands in 2023.
Noting he has witnessed the vigorous growth of China-South Africa relations, Xi, on his fourth state visit to South Africa, said that he hopes both countries will continue their friendship and deepen cooperation.
The last three state visits made by Xi to South Africa were in 2013, 2015 and 2018.
Lifting ties
This year marks the 25th anniversary of the establishment of diplomatic relations between China and South Africa. In the past 25 years, the bilateral relationship has been promoted from being a partnership to a strategic partnership, and then to a comprehensive strategic partnership.
In the article titled “Sailing the Giant Ship of China-South Africa Friendship and Cooperation Toward Greater Success”, Xi said the relationship between China and Africa is one of the most vibrant in the developing world, adding that it has entered a “golden era” with a promising future.
With South Africa officially becoming the only African member in 2011, BRIC was enlarged to BRICS. In 2015, South Africa became the first African country to sign a Belt and Road Initiative cooperation document.
Now at a new historical point, Xi said he is willing to work with his South African counterpart to push the China-South Africa comprehensive strategic partnership to a new level.
Deepening cooperation
Noting bilateral relations are at a new starting point, Xi said deepening cooperation and strengthening coordination is the common aspiration of the two countries and the task entrusted by the times.
In the first half of 2023, bilateral trade between China and South Africa reached $28.25 billion, up 11.7 percent year-on-year, said Shu Jueting, a spokesperson of the Ministry of Commerce, adding that China has maintained its position as South Africa’s largest trading partner for 14 consecutive years, while South Africa has been China’s largest trading partner in Africa for 13 consecutive years.
With an investment stock of more than $10 billion, China is one of the major sources of investment in South Africa, said the spokesperson.
Specifically speaking, the two sides have together constructed and commissioned over 10,000 km of railway, nearly 100,000 km of highway, and an array of important infrastructure projects, including airports, docks, bridges and power plants, according to China’s Ministry of Commerce.
Besides, the two major developing countries have in recent years also collaborated on a variety of projects in relation to the digital economy, high-end technology and clean energy.
Carrying forward friendship
Aside from the booming bilateral trade, the two countries also boast fruitful cooperation in education, culture and other fields, letting people of both countries know each other better.
Besides holding three meetings of the South Africa-China High-level People-To-People Exchange Mechanism, China and South Africa are also jointly building the Luban Workshop – a Chinese vocational workshop program training talents overseas – to promote vocational education exchanges and cooperation between both countries, said Chen Xiaodong, the Chinese ambassador to South Africa.
Siyabonga Cyprian Cwele, South African Ambassador to China, noted that the South African people love Chinese films and TV shows, as well as Chinese kung fu and Chinese history.
In the past decade, more and more students from South Africa and China have studied in each other’s countries.
Acknowledging that South Africa integrated teaching Chinese language into its national education system in 2015, Cwele said many South African tour guides are also learning Chinese.
At present, more than 10 universities in China have established partnerships with universities in South Africa, including the partnership between Northeast Normal University in northeast China’s Jilin City and the University of Pretoria in South Africa in 2012.
Hailing the deep friendship of “comrades and brothers” between China and Africa, Xi said carrying forward friendship at the new historical starting point is the task trusted by the times.
https://news.cgtn.com/news/2023-08-22/How-China-S-Africa-usher-in-golden-era-for-bilateral-ties-1mtRFQB6wpi/index.html
View original content:https://www.prnewswire.co.uk/news-releases/cgtnhow-china-s-africa-usher-in-golden-era-for-bilateral-ties-301907647.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News5 days ago
Clayfin Technologies and Jana Small Finance Bank Honored with Prestigious IBSi Digital Banking Award 2024
-
Latest News5 days ago
HANDSHAKE SPEAKEASY IN MEXICO CITY NAMED AS THE BEST BAR IN NORTH AMERICA AS RANKING OF NORTH AMERICA’S 50 BEST BARS IS REVEALED AT THIRD ANNUAL AWARDS CEREMONY
-
Latest News4 days ago
Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade
-
Latest News6 days ago
Nium Expands Regional Footprint in Asia; Signs Partnership MOU with Indonesian Payments Infrastructure Leader, Artajasa
-
Latest News7 days ago
Colombia to showcase sustainable investment opportunities at the Investment Roadshow in London
-
Latest News4 days ago
BINGHATTI LAUNCHES ITS DEBUT PROJECT ADJACENT TO DUBAI HILLS
-
Latest News5 days ago
SDAX Unveils World’s First Securitised Gold Tokens for Digital Exchange Users
-
Latest News5 days ago
Allfunds has partnered with Google Cloud to leverage AI-powered innovation and optimize its infrastructure.